Advertisement
Advertisement

INBX

INBX logo

Inhibrx Biosciences, Inc. Common Stock

92.38
USD
Sponsored
-0.73
-0.78%
Aug 11, 16:00 UTC -4
Closed
exchange

After-Market

92.31

-0.07
-0.08%

Inhibrx Biosciences, Inc. Common Stock Profile

About

Inhibrx Inc. is a clinical-stage biopharmaceutical company. It focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO.

Info & Links

CEO

Mark P. Lappe

Headquarters

11025 N. TORREY PINES ROAD, SUITE 140
LA JOLLA, CA 92037, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://inhibrx.com

Auditor

BDO USA, P.C.

Share holders

6

Employees

110

Inhibrx Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.35B

Enterprise Value

1.37B

Enterprise Value/EBITDA(ttm)

-11.33

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-551.04%

Return on Equity(ttm)

-563.90%

Return on Invested Capital(ttm)

-94.82%

Return on Assets(ttm)

-72.32%

Income Statement

Revenue(ttm)

1.30M

Revenue Per Share(ttm)

0.09

Gross Profit(ttm)

1.30M

EBITDA(ttm)3

-120.71M

Net Income Available to Common(ttm)

-130.19M

Diluted EPS(ttm)

-8.39

Share Statistics

Beta (5Y Monthly)

3.51

52-Week Change

338.65%

S&P 500 52-Week Change

19.90%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

14.67M

Dividend Yield

0.00%

Float4

11.99M

% Held by Insiders

18.26%

% Held by Institutions

82.46%

Balance Sheet

Total Cash(mrq)

161.66M

Total Cash Per Share(mrq)

11.02

Total Debt(mrq)

174.99M

Total Debt/Equity(mrq)

-831.92%

Current Ratio(mrq)

6.46%

Quick Ratio(mrq)

6.46%

Book Value Per Share(mrq)

-1.44

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.44

Free Cash Flow(ytd)

-38.03M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement